Defining infection risk of bispecific antibodies for myeloma. [PDF]
Blood AdvHammond SP.
europepmc +1 more source
Assessing the Safety of a Novel Monoclonal Antibody Cocktail for Postexposure Prophylaxis in Category III Animal Exposures. [PDF]
Int J Appl Basic Med ResSingh A +7 more
europepmc +1 more source
Adverse effects of biologics used to treat asthma. [PDF]
Ther Adv Respir DisSitek A, Chiarella SE, Pongdee T.
europepmc +1 more source
Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women. [PDF]
Pharmacol Res PerspectBrimhall DB +4 more
europepmc +1 more source
Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo® Tablets. [PDF]
Drugs R DMishima K, Fujimoto K, Endo A, Ishii M.
europepmc +1 more source
Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey. [PDF]
Low Urin Tract SymptomsYoshimura S, Yagi H, Abe K, Yamasaki M.
europepmc +1 more source
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment. [PDF]
Ther Innov Regul SciAlexe A +9 more
europepmc +1 more source
Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
J Clin Endocrinol MetabHuang J, Su A, Yang J, Zhuang W, Li Z.
europepmc +1 more source
Safety Evaluation of the Novel Cocktail of Monoclonal Antibodies for Postexposure Prophylaxis in Category III Animal Exposures. [PDF]
J Glob Infect DisShankaraiah RH +7 more
europepmc +1 more source